share_log

HC Wainwright & Co. Upgrades AcelRx Pharmaceuticals to Buy, Announces $8 Price Target

HC Wainwright & Co. Upgrades AcelRx Pharmaceuticals to Buy, Announces $8 Price Target

HC Wainwright & Co.將AcelRx Pharmicals升級爲收購,宣佈目標股價爲8美元
Benzinga ·  2023/08/18 06:21

HC Wainwright & Co. analyst Ed Arce upgrades AcelRx Pharmaceuticals (NASDAQ:ACRX) from Neutral to Buy and announces $8 price target.

HC Wainwright & Co. 分析師埃德·阿斯將AcelRX Pharmicals(納斯達克股票代碼:ACRX)從中性上調至買入,並宣佈目標股價爲8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論